Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Which Indices Are Most Followed By Investors highlights the benchmarks that attract the most attention from market participants and why their popularity matters.
27,878 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
A rising pushback against data centers is reshaping the debate over AI infrastructure. This article breaks down what ...
Webull (Bull) 2025 earnings offer a window into user growth, revenue mix, and paths to profitability. This guide brea...
Chewy has shown growth in revenue alongside margin pressures as it scales its e-commerce pet-products platform. This ...
A surge in AI and software stocks is driving big, daily swings in CEO wealth even as pay packages grow. Investors oft...
FuboTV has faced a brutal stretch, yet new synergies from Disney and Hulu may set up a rebound in EBITDA and subscrib...
A broad sell-off hit four key quantum names after a sharp Monday rally, with profit-taking and sentiment shifts weigh...
One mega-cap could re-enter the elite $4 trillion club, powered by AI, cloud momentum, and strong cash flow. This pie...
Is intuitive surgical right now? The robotics leader faces macro headwinds and strong long term demand. This guide br...
Costco reports solid membership-driven results in mid-2026, but the stock faces a high bar for growth and valuation. ...
Kick back this weekend with 10 thoughtful weekend reads that bridge big ideas and real-world investing. Each piece of...
If SpaceX shifts a sizable slice of its IPO to everyday investors, the market could see bigger demand and new pricing...